相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adoptive Immunotherapy beyond CAR T-Cells
Aleksei Titov et al.
CANCERS (2021)
Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy
Oscar Fabian Garcia-Aponte et al.
JOURNAL OF BIOLOGICAL ENGINEERING (2021)
Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy
Marta Grau-Vorster et al.
FRONTIERS IN IMMUNOLOGY (2020)
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks
Pierangela Palmerini et al.
CYTOTHERAPY (2020)
Enabling Large-Scale Ex Vivo Production of Megakaryocytes from CD34+ Cells Using Gas-Permeable Surfaces
Andres F. Martinez et al.
STEM CELLS TRANSLATIONAL MEDICINE (2019)
Streamlined production of genetically modified T cells with activation, transduction and expansion in closed-system G-Rex bioreactors
Christine Gagliardi et al.
CYTOTHERAPY (2019)
In Vitro Expansion of Anti-viral T Cells from Cord Blood by Accelerated Co-cultured Dendritic Cells
Klaudia Kuranda et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Large-scale in vitro production of red blood cells from human peripheral blood mononuclear cells
Steven Heshusius et al.
BLOOD ADVANCES (2019)
Automated Clinical Grade Expansion of Regulatory T Cells in a Fully Closed System
Jose Manuel Marin Morales et al.
FRONTIERS IN IMMUNOLOGY (2019)
Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells
Lin Xiao et al.
CYTOTHERAPY (2018)
Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors
Josee Golay et al.
CYTOTHERAPY (2018)
The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy
Sarah L. Buchan et al.
BLOOD (2018)
Advances in umbilical cord blood cell therapy: the present and the future
Sofia Berglund et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
CIK as therapeutic agents against tumors
M. Introna
JOURNAL OF AUTOIMMUNITY (2017)
Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
Claudio G. Brunstein et al.
BLOOD (2016)
The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacity
Marie-Andree Forget et al.
ONCOIMMUNOLOGY (2016)
Low-cost generation of Good Manufacturing Practice-grade CD19-specific chimeric antigen receptor-expressing T cells using piggyBac gene transfer and patient-derived materials
Saumya Ravianayake et al.
CYTOTHERAPY (2015)
Early exposure to interleukin-21 limits rapidly generated anti-Epstein-Barr virus T-cell line differentiation
Julie Orio et al.
CYTOTHERAPY (2015)
A Novel Method Using Blinatumomab for Efficient, Clinical-Grade Expansion of Polyclonal T Cells for Adoptive Immunotherapy
Josee Golay et al.
JOURNAL OF IMMUNOLOGY (2014)
Optimizing the production of suspension cells using the G-Rex M series
Pradip Bajgain et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease
Rikhia Chakraborty et al.
HAEMATOLOGICA (2013)
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
Natalia Lapteva et al.
CYTOTHERAPY (2012)
Simplified Method of the Growth of Human Tumor Infiltrating Lymphocytes in Gas-permeable Flasks to Numbers Needed for Patient Treatment
Jianjian Jin et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2012)
Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies
Alice Pievani et al.
BLOOD (2011)
Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab
Dirk Nagorsen et al.
EXPERIMENTAL CELL RESEARCH (2011)
Optimization Manufacture of Virus- and Tumor-Specific T Cells
Natalia Lapteva et al.
STEM CELLS INTERNATIONAL (2011)
Therapeutic efficacy of the pan-cdk inhibitor PHA-793887 in vitro and in vivo in engraftment and high-burden leukemia models
Rachele Alzani et al.
EXPERIMENTAL HEMATOLOGY (2010)
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes
Marta Franceschetti et al.
EXPERIMENTAL HEMATOLOGY (2009)
In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity
Ryosei Nishimura et al.
BLOOD (2008)
Bioreactor development for stem cell expansion and controlled differentiation
James A. King et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2007)
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study
Martino Introna et al.
HAEMATOLOGICA (2007)
分享论文
